KR840002292B1 - 2-[3-[4(3-클로로-4-플루오르페닐)-1-피페라지닐]프로필]-1,2,4-트리아졸로[4,3-a]피리딘-3(2H)-온의 제조방법 - Google Patents

2-[3-[4(3-클로로-4-플루오르페닐)-1-피페라지닐]프로필]-1,2,4-트리아졸로[4,3-a]피리딘-3(2H)-온의 제조방법 Download PDF

Info

Publication number
KR840002292B1
KR840002292B1 KR1019810001166A KR810001166A KR840002292B1 KR 840002292 B1 KR840002292 B1 KR 840002292B1 KR 1019810001166 A KR1019810001166 A KR 1019810001166A KR 810001166 A KR810001166 A KR 810001166A KR 840002292 B1 KR840002292 B1 KR 840002292B1
Authority
KR
South Korea
Prior art keywords
chloro
propyl
triazolo
pyridin
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019810001166A
Other languages
English (en)
Korean (ko)
Other versions
KR830005218A (ko
Inventor
부루노실베스트리니
바이오치 레오나르도
Original Assignee
아진데 치미체 리우니테 안젤리니 후란시스코 에이. 씨. 알. 에이. 에프. 쏘시에떼퍼 아찌오니
마리오 기오바니갈라지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아진데 치미체 리우니테 안젤리니 후란시스코 에이. 씨. 알. 에이. 에프. 쏘시에떼퍼 아찌오니, 마리오 기오바니갈라지 filed Critical 아진데 치미체 리우니테 안젤리니 후란시스코 에이. 씨. 알. 에이. 에프. 쏘시에떼퍼 아찌오니
Publication of KR830005218A publication Critical patent/KR830005218A/ko
Application granted granted Critical
Publication of KR840002292B1 publication Critical patent/KR840002292B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019810001166A 1980-04-09 1981-04-07 2-[3-[4(3-클로로-4-플루오르페닐)-1-피페라지닐]프로필]-1,2,4-트리아졸로[4,3-a]피리딘-3(2H)-온의 제조방법 Expired KR840002292B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21246A/80 1980-04-09
IT21246/80A IT1147349B (it) 1980-04-09 1980-04-09 2-parentesi quadra aperta 3-parentesi quadra aperta 4-(3-cloro-4-fluorofenil)-1-piperfrazinil parentesi quadra propil parentesi quadra chiusa-1,2,4-triazolo parentesi quadra aperta 4,3 parentesi quadra chiusa piridin-3(2h)-one

Publications (2)

Publication Number Publication Date
KR830005218A KR830005218A (ko) 1983-08-03
KR840002292B1 true KR840002292B1 (ko) 1984-12-15

Family

ID=11178966

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810001166A Expired KR840002292B1 (ko) 1980-04-09 1981-04-07 2-[3-[4(3-클로로-4-플루오르페닐)-1-피페라지닐]프로필]-1,2,4-트리아졸로[4,3-a]피리딘-3(2H)-온의 제조방법

Country Status (21)

Country Link
US (1) US4402956A (enExample)
JP (1) JPS56158784A (enExample)
KR (1) KR840002292B1 (enExample)
AR (1) AR225076A1 (enExample)
AT (1) AT377262B (enExample)
AU (1) AU529605B2 (enExample)
BE (1) BE887547A (enExample)
CA (1) CA1176253A (enExample)
CH (1) CH652397A5 (enExample)
DE (1) DE3112984A1 (enExample)
ES (1) ES501188A0 (enExample)
FI (1) FI69306C (enExample)
FR (1) FR2480285A1 (enExample)
GB (1) GB2073747B (enExample)
GR (1) GR73620B (enExample)
IL (1) IL62101A (enExample)
IT (1) IT1147349B (enExample)
NL (1) NL8100998A (enExample)
PT (1) PT72813B (enExample)
SE (1) SE442201B (enExample)
YU (1) YU83181A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5432698A (en) 1996-11-12 1998-06-03 Sepracor, Inc. 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
EP0938487A2 (en) * 1996-11-12 1999-09-01 Sepracor, Inc. 2$i(R),4$i(S),$i(R),$i(S)- AND 2$i(S),4$i(R),$i(R),$i(S)-HYDROXYITRACONAZOLE- AND HYDROXYSAPERCONAZOLE DERIVATIVES
US6147077A (en) * 1999-04-29 2000-11-14 Sepracor Inc. 2R,4S-hydroxyitraconazole isomers
EP2303897A4 (en) * 2008-06-05 2012-02-22 Harvard College HIGH VALENCIA PALLADIUM FLUORIDE COMPLEXES AND USES THEREOF
WO2010059943A2 (en) 2008-11-20 2010-05-27 President And Fellows Of Harvard College Fluorination of organic compounds
AU2010203461A1 (en) * 2009-01-09 2011-07-28 President And Fellows Of Harvard College Fluorine containing compounds and methods of use thereof
CN103596931B (zh) 2011-04-12 2016-10-12 哈佛大学校长及研究员协会 有机化合物的氟化
WO2014052622A1 (en) 2012-09-26 2014-04-03 President And Fellows Of Harvard College Nickel fluorinating complexes and uses thereof
US10759764B2 (en) 2013-10-18 2020-09-01 President And Fellows Of Harvard College Fluorination of organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
FR8135M (enExample) * 1968-12-31 1970-08-10
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
UST100505I4 (en) 1980-03-17 1981-04-07 Triazolo[4,3-a]pyridin-3(2H)-ones

Also Published As

Publication number Publication date
US4402956A (en) 1983-09-06
JPS56158784A (en) 1981-12-07
ATA165081A (de) 1984-07-15
PT72813A (en) 1981-05-01
PT72813B (en) 1982-04-02
KR830005218A (ko) 1983-08-03
CA1176253A (en) 1984-10-16
DE3112984A1 (de) 1981-12-24
FR2480285B1 (enExample) 1984-02-24
SE442201B (sv) 1985-12-09
IT1147349B (it) 1986-11-19
SE8102093L (sv) 1981-10-10
GB2073747A (en) 1981-10-21
NL8100998A (nl) 1981-11-02
IT8021246A0 (it) 1980-04-09
AU6904381A (en) 1981-10-15
CH652397A5 (it) 1985-11-15
GB2073747B (en) 1983-09-07
IL62101A0 (en) 1981-03-31
FI811000L (fi) 1981-10-10
AT377262B (de) 1985-02-25
ES8202817A1 (es) 1982-02-01
FR2480285A1 (fr) 1981-10-16
ES501188A0 (es) 1982-02-01
FI69306C (fi) 1986-01-10
YU83181A (en) 1983-12-31
AU529605B2 (en) 1983-06-16
BE887547A (fr) 1981-06-15
AR225076A1 (es) 1982-02-15
FI69306B (fi) 1985-09-30
GR73620B (enExample) 1984-03-26
IL62101A (en) 1984-01-31

Similar Documents

Publication Publication Date Title
JP2018524298A (ja) リンパ腫を処置するためのｅｚｈ２阻害剤
CS258119B2 (en) Method of 1-heteroaryl-4(2,5-pyrrolidione-1-yl)alkyl)piperazine derivatives production
HUP0204458A2 (hu) Alfa-2-antagonista hatású kinolinszármazékok és ezeket tartalmazó gyógyszerkészítmények
ES2929140T3 (es) Imidazoles sustituidos con fenilo y piridinilo como moduladores de RORgammat
KR840002292B1 (ko) 2-[3-[4(3-클로로-4-플루오르페닐)-1-피페라지닐]프로필]-1,2,4-트리아졸로[4,3-a]피리딘-3(2H)-온의 제조방법
RU2021269C1 (ru) Пиридил- или пиримидилсодержащие производные пиперазина или 1,4-диазациклогептана или их фармакологически активные кислотно-аддитивные соли, обладающие психотропным действием
JP2016185947A (ja) ＩＲＥ−１αインヒビター
EA004053B1 (ru) Производные бензотиадиазина, способ их получения, фармацевтические композиции и применение
AU2005266493B2 (en) Inhibitors of Hsp90
KR100227953B1 (ko) 신규한 3,4-디하이드로이소퀴놀린 유도체, 및 카보사이클 및 헤테로사이클 융합된 디하이드로피리딘 및 이들을 함유하는 약제학적 제제
US6903132B2 (en) Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
WO2022005961A1 (en) Prpk inhibitors
HU193333B (en) Process for production of 2-amino-axazilons and medical preparatives containing thereof
US3632587A (en) Piperazino methyl isatinylidine 3 acetates
EP4387959A1 (en) Preparation of a p2x3 antagonist
JPH08502057A (ja) カルモジュリン拮抗特性を有する複素環式アミン
BG63336B1 (bg) Нови производни на хидроксамови киселини, фармацевтични състави на тяхна основа и метод за получаването им
EP0724584A1 (en) Heterocyclic amines having central nervous system activity
JPH08283219A (ja) アラルキルアミノアルキルアミド誘導体
JP2021104931A (ja) 含窒素複素環を有するジベンゾアゼピン誘導体
EP1544201B1 (en) Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
AP899A (en) Indole derivatives useful in therapy.
US3462434A (en) 2-isopropyl-3-(p-amino-phenyl)-3h-4-quinazolone
HK40084747A (en) Preparation of a p2x3 antagonist
HU201002B (en) Process for production of derivatives of indan sulphamid and medical compositions containing them

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000